San Francisco, CA, United States of America

Mohammad Muneeb Sultan

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Insitro, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mohammad Muneeb Sultan: Innovator in Disease Modeling through Microscopy Image Analysis.

Introduction

Mohammad Muneeb Sultan is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of disease modeling through innovative technologies. His work focuses on utilizing microscopy image analyses to develop machine learning models that can effectively distinguish between healthy and diseased samples.

Latest Patents

Sultan holds a patent for "Microscopy image analyses for disease modeling." This patent encompasses systems and non-transitory computer-readable media designed for analyzing microscopy images. The technology captures images from cells exhibiting various exposure response phenotypes (ERPs) and employs them to train machine learning models. These trained models enhance the ability to differentiate between healthy and diseased samples, thereby advancing the field of medical diagnostics.

Career Highlights

Currently, Mohammad Muneeb Sultan is employed at Insitro, Inc., where he continues to push the boundaries of innovation in the life sciences sector. His work is pivotal in integrating machine learning with biological research, which has the potential to revolutionize how diseases are understood and treated.

Collaborations

Sultan collaborates with notable professionals in his field, including Daphne Koller and Ajamete Kaykas. These partnerships foster a dynamic environment for research and development, enhancing the impact of their collective work.

Conclusion

In summary, Mohammad Muneeb Sultan is a key figure in the intersection of microscopy and machine learning, with a focus on disease modeling. His innovative patent and contributions at Insitro, Inc. highlight his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…